Skip to search formSkip to main contentSkip to account menu

McN 3716

Known as: McN-3716 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

methyl 2-tetradecylglycidate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
Incorporation of [ U-i 4 C ] palmitate into rat brain : effect of an inhibitor of P-oxidation
We examined the effect of a clinically therapeutic dose of methyl 2-tetradecylglycidate (McN-3716, methyl palmoxirate, MEP) (2.5… 
1993
1993
Effects of blockade of fatty acid oxidation on whole body and tissue-specific glucose metabolism in rats.
We examined the effect of the long-chain fatty acid oxidation blocker methyl palmoxirate (methyl 2-tetradecyloxiranecarboxylate… 
1984
1984
Effects of the oral hypoglycemic agent methyl palmoxirate on exercise capacity of rats.
The effect of the oral hypoglycemic agent methyl palmoxirate (methyl 2-tetradecylglycidate, McN-3716), a selective inhibitor of… 
Highly Cited
1979
Highly Cited
1979
Action of the oral hypoglycemic agent 2-tetradecylglycidic acid on hepatic fatty acid oxidation and gluconeogenesis.
Using isolated hepatocytes from fasted rats, the oral hypoglycemic agents, Z-tetradecylglycidic acid (McN3802) and its methyl… 
Highly Cited
1979
Highly Cited
1979
Methyl 2-Tetradecylglycidate, An Orally Effective Hypoglycemic Agent that Inhibits Long Chain Fatty Acid Oxidation Selectively
The oral hypoglycemic agents methyl 2-tetradecylglycidate (McN-3716) and 2-tetradecylglycidic acid (McN-3802), synthesized in an… 
Highly Cited
1978
Highly Cited
1978
Pharmacologic profile of methyl 2-tetradecylglycidate (McN-3716)--an orally effective hypoglycemic agent.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)